| Symbol |
Name |
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANXA1
|
annexin A1
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ATM
|
ATM serine/threonine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CCND1
|
cyclin D1
|
|
CD109
|
CD109 molecule
|
|
CD274
|
CD274 molecule
|
|
CD82
|
CD82 molecule
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CSN1S1
|
casein alpha s1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FHIT
|
fragile histidine triad
|
|
FSD1
|
fibronectin type III and SPRY domain containing 1
|
|
FSD1L
|
fibronectin type III and SPRY domain containing 1-like
|
|
GPS1
|
G protein pathway suppressor 1
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
LAMC2
|
laminin, gamma 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
THBS1
|
thrombospondin 1
|
|
TP53
|
tumor protein p53
|
|
VEGFA
|
vascular endothelial growth factor A
|
